ISRG vs BSX
ISRG and BSX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ISRGIntuitive Surgical, Inc. | BSXBOSTON SCIENTIFIC CORPORATION |
|---|---|---|
| Market cap | $151.93B | $63.74B |
| P/E (TTM) | 53.0 | 17.8 |
| P/B | 9.50 | 2.56 |
| P/S | 15.1x | 3.1x |
| Revenue | $11.58B(TTM) | $21.00B(TTM) |
| Revenue growth (YoY) | 20.5% | 19.9% |
| Net income | $2.96B(TTM) | $3.67B(TTM) |
| Earnings growth (YoY) | 23.0% | 56.7% |
| EPS, diluted | $8.27(TTM) | $2.47(TTM) |
| EBIT margin | 29.3% | 18.0% |
| ROE | 17.9% | 11.6% |
| ROIC | — | 10.0% |
| Piotroski F | — | 8/9 |
| 1y total return | -18.1% | -56.8% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ISRG frente a BSX
| Métrica | ISRG | BSX |
|---|---|---|
| Valor final | $59.6K | $18.8K |
| Retorno total | +496.5% | +88.0% |
| CAGR | +18.9% | +6.3% |
| Volatilidad | 32.8% | 27.6% |
| Sharpe | 0.56 | 0.21 |
| Sortino | 0.82 | 0.28 |
| Caída máxima | -49.9% | -61.5% |
Basado en 2600 días de negociación comunes, 2016-06-30 → 2026-11-02 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)